NodThera_logo.jpg
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
August 01, 2024 07:00 ET | NodThera
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer Greg brings over 25 years of public and private company leadership experience Philadelphia, PA, August 1, 2024 -...
800 px horizontal logo.png
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
July 30, 2024 09:00 ET | Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
Fractyl-Logo.png
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
July 30, 2024 07:00 ET | Fractyl Health, Inc.
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
Zealand Logo (1).png
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
July 29, 2024 11:00 ET | Zealand Pharma
Press release – 7 / 2024 Zealand Pharma Appoints Eric Cox as Chief Commercial Officer Copenhagen, Denmark, 29 July 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a...
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics Selects Obesity and Related Metabolic Complications as Lead Indication for Inflammasome ASC Inhibitor IC 100
July 25, 2024 07:57 ET | ZyVersa Therapeutics
WESTON, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for...
Obesity Canada logo-en-fr-hor-vert-F2.jpg
Obesity Canada Appoints Lisa Schaffer as New Executive Director
July 09, 2024 07:00 ET | Obesity Canada
EDMONTON, Alberta, July 09, 2024 (GLOBE NEWSWIRE) -- Obesity Canada is pleased to announce the appointment of Lisa Schaffer as the new Executive Director, following an extensive search process. Lisa...
22157.jpg
Digital Health for Obesity: A $457.4 Billion Global Market by 2034 - Uncover the Segments and Countries Projected to Experience the Fastest Growth, Along with Profiles of the Leading Players
July 01, 2024 09:25 ET | Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Global Digital Health for Obesity Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
22157.jpg
Anti-obesity Medication Market Analysis 2024-2034 by Product, Mechanism of Action, Distribution Channel and Region - Global Industry Projected to Register 31.71% CAGR, Reaching $137.4 Billion by 2034
June 26, 2024 06:55 ET | Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market" report has been added to ResearchAndMarkets.com's offering.The global anti-obesity medication market accounted...
Fractyl-Logo.png
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
June 25, 2024 07:00 ET | Fractyl Health, Inc.
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Cardiometabolic Heal
Cardiometabolic Health Congress (CMHC) will present the results of a webcast series designed to help practitioners improve patient care
June 24, 2024 10:48 ET | Cardiometabolic Health Congress
Boca Raton, FL, June 24, 2024 (GLOBE NEWSWIRE) -- The ADA 2024 Scientific Sessions center on the latest cutting-edge advances in diabetes research, prevention, and care. The event will be held June...